Exclusionary bathroom policies harm transgender students
Transgender students’ health, safety and well-being is jeopardized when they’re forced to use bathrooms that don’t match gender identity, physicians say.
AMA supports FDA’s changes to prescription opioids labels
AMA welcomes FDA including tapering guidance on prescription opioid labels, changes mirror points that AMA has emphasized in efforts to end the opioid epidemic.
Quick Take: Moves cut barriers to opioid-use disorder treatment
In actions that will save lives, New Jersey and Washington, D.C., removed prior authorization for Medicaid patients who need medication-assisted treatment.
Quick Take: Action on drug pricing gets massive bipartisan support
Legislation to speed generic drugs to market, improving price transparency and boost competition could soon come to the House floor.
District of Columbia takes important step to reverse opioid epidemic
The MSDC and the AMA applauded the mayor’s office for removing prior authorization for medications to treat opioid use disorder.
Patient Support & Advocacy
Surprise billing: 7 principles to fix a broken system
Narrow, inadequate physician networks can mean unanticipated costs for patients. Here’s what doctors should know, and what Congress should keep in mind.
AMA stands up for ACA patient protections in federal court
The AMA, joined by several other physician organizations, opposed a court decision striking down the Affordable Care Act and the patient protections that would go with it.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights
Get Advocacy Update
The newsletter includes exclusive news on key national and state issues, a cutting-edge guide to physician advocacy and discounts on state and federal conferences.Subscribe Now